[P25-7] P25-7: Immunosuppressive drugs (2): Monoclonal antibody and genotyping

[P25-7-6] TDM of infliximab by LC-MS/MS using nSMOL in patients with inflammatory bowel disease

Atsushi Yonezawa¹, Yasuaki Ikemi², Yuki Otani³, Syo Masui⁴, Satoshi Imai⁵, Shunsaku Nakagawa⁶, Noriko Iwamoto⁷, Takashi Shimada⁸, Minoru Matsuura⁹, Hiroshi Nakase¹⁰, Kazuo Matsubara¹¹ (1.Kyoto University Hospital, 2.Kyoto University Hospital, 3.Kyoto University Hospital, 4.Kyoto University Hospital, 5.Kyoto University Hospital, 6.Kyoto University Hospital, 7.SHIMADZU Corporation, 8.SHIMADZU Corporation, 9.Kyoto University, 10.Kyoto University, 11.Kyoto University Hospital)

Keywords:Infliximab, anti-drug antibody, LC-MS/MS, tumor necrosis factor alpha, inflammatory bowel disease